Home
About
Overview
Sharing Data
ORCID
Help
History (39)
Molecular Profiling of Syringocystadenocarcinoma Papilliferum Reveals RAS-Activating Mutations.
Tobacco Use Cessation Products
Lysine-containing cationic liposomes activate the NLRP3 inflammasome: Effect of a spacer between the head group and the hydrophobic moieties of the lipids.
Cytogenetic bands and sharp peaks of Alu underlie large-scale segmental regulation of nuclear genome architecture.
Clinical Trial Design for Alcoholic Hepatitis.
See All 39 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Trial Design for Alcoholic Hepatitis.
Szabo G. Clinical Trial Design for Alcoholic Hepatitis. Semin Liver Dis. 2017 11; 37(4):332-342.
View in:
PubMed
subject areas
Clinical Trials as Topic
Hepatitis, Alcoholic
Humans
Research Design
Treatment Outcome
authors with profiles
Gyongyi Szabo MD, PhD